141 related articles for article (PubMed ID: 28093224)
1. Beta-2-adrenoreceptor polymorphism at position 16 determines the clinical severity of chronic obstructive pulmonary disease.
Emeryk-Maksymiuk J; Emeryk A; Krawczyk P; Wojas-Krawczyk K; Milanowski J
Pulm Pharmacol Ther; 2017 Apr; 43():1-5. PubMed ID: 28093224
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms of the beta2 adrenoreceptor gene in chronic obstructive pulmonary disease.
Vacca G; Schwabe K; Dück R; Hlawa HP; Westphal A; Pabst S; Grohé C; Gillissen A
Ther Adv Respir Dis; 2009 Feb; 3(1):3-10. PubMed ID: 19293197
[TBL] [Abstract][Full Text] [Related]
3. Effect of polymorphisms in the β2-adrenergic receptor on the susceptibility and pulmonary function of patients with chronic obstructive pulmonary disease: a meta analysis.
Niu LM; Liang Y; Xu M; Zhang YY; Zhang Y; He B
Chin Med J (Engl); 2012 Jun; 125(12):2213-8. PubMed ID: 22884155
[TBL] [Abstract][Full Text] [Related]
4. Effect of ADRB2 polymorphisms on the efficacy of salmeterol and tiotropium in preventing COPD exacerbations: a prespecified substudy of the POET-COPD trial.
Rabe KF; Fabbri LM; Israel E; Kögler H; Riemann K; Schmidt H; Glaab T; Vogelmeier CF
Lancet Respir Med; 2014 Jan; 2(1):44-53. PubMed ID: 24461901
[TBL] [Abstract][Full Text] [Related]
5. Beta
Hussein MH; Sobhy KE; Sabry IM; El Serafi AT; Toraih EA
Adv Med Sci; 2017 Mar; 62(1):193-201. PubMed ID: 28327457
[TBL] [Abstract][Full Text] [Related]
6. Beta2-adrenergic receptor genetic polymorphisms and short-term bronchodilator responses in patients with COPD.
Hizawa N; Makita H; Nasuhara Y; Betsuyaku T; Itoh Y; Nagai K; Hasegawa M; Nishimura M
Chest; 2007 Nov; 132(5):1485-92. PubMed ID: 17890463
[TBL] [Abstract][Full Text] [Related]
7. Association of beta2-adrenoreceptor genotypes with bronchodilatory effect of tiotropium in COPD.
Umeda N; Yoshikawa T; Kanazawa H; Hirata K; Fujimoto S
Respirology; 2008 May; 13(3):346-52. PubMed ID: 18399855
[TBL] [Abstract][Full Text] [Related]
8. Genetic Polymorphism of CHRM2 in COPD: Clinical Significance and Therapeutic Implications.
Cherubini E; Esposito MC; Scozzi D; Terzo F; Osman GA; Mariotta S; Mancini R; Bruno P; Ricci A
J Cell Physiol; 2016 Aug; 231(8):1745-51. PubMed ID: 26633752
[TBL] [Abstract][Full Text] [Related]
9. Variants of the ADRB2 Gene in COPD: Systematic Review and Meta-Analyses of Disease Risk and Treatment Response.
Nielsen AO; Jensen CS; Arredouani MS; Dahl R; Dahl M
COPD; 2017 Aug; 14(4):451-460. PubMed ID: 28506092
[TBL] [Abstract][Full Text] [Related]
10. β
Ingebrigtsen TS; Vestbo J; Rode L; Marott JL; Lange P; Nordestgaard BG
Thorax; 2019 Oct; 74(10):934-940. PubMed ID: 31481635
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of the β2-adrenoreceptor and M3-cholinoreceptor genes in bronchial mucosa of patients with asthma and chronic obstructive pulmonary disease.
Selivanova PA; Kulikov ES; Kozina OV; Trofimenko IN; Freidin MB; Chernyak BA; Ogorodova LM
Ann Allergy Asthma Immunol; 2012 Jan; 108(1):39-43. PubMed ID: 22192964
[TBL] [Abstract][Full Text] [Related]
12. A functional SNP upstream of the
Li JX; Fu WP; Zhang J; Zhang XH; Sun C; Dai LM; Zhong L; Yu L; Zhang YP
Int J Chron Obstruct Pulmon Dis; 2018; 13():917-925. PubMed ID: 29588580
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms of IL4, IL13, and ADRB2 genes in COPD.
Hegab AE; Sakamoto T; Saitoh W; Massoud HH; Massoud HM; Hassanein KM; Sekizawa K
Chest; 2004 Dec; 126(6):1832-9. PubMed ID: 15596681
[TBL] [Abstract][Full Text] [Related]
14. Beta2-adrenergic receptor haplotype and bronchodilator response to salbutamol in patients with acute exacerbations of COPD.
Mokry M; Joppa P; Slaba E; Zidzik J; Habalova V; Kluchova Z; Micietova L; Rozborilova E; Salagovic J; Tkacova R
Med Sci Monit; 2008 Aug; 14(8):CR392-8. PubMed ID: 18667995
[TBL] [Abstract][Full Text] [Related]
15. β(2) -adrenoreceptor polymorphisms in asthmatic and non-asthmatic schoolchildren from Colombia and their relationship to treatment response.
Isaza C; Sepúlveda-Arias JC; Agudelo BI; Arciniegas W; Henao J; Porras GL; Beltrán L
Pediatr Pulmonol; 2012 Sep; 47(9):848-55. PubMed ID: 22328447
[TBL] [Abstract][Full Text] [Related]
16. [Acute exacerbations of chronic obstructive pulmonary disease].
Chabot F; Gomez E; Guillaumot A; Kheir A; Chaouat A
Presse Med; 2009 Mar; 38(3):485-95. PubMed ID: 19185446
[TBL] [Abstract][Full Text] [Related]
17. A pharmacogenetic study of ADRB2 polymorphisms and indacaterol response in COPD patients.
Yelensky R; Li Y; Lewitzky S; Leroy E; Hurwitz C; Rodman D; Trifilieff A; Paulding CA
Pharmacogenomics J; 2012 Dec; 12(6):484-8. PubMed ID: 22158330
[TBL] [Abstract][Full Text] [Related]
18. Clinical course of COPD in patients with Arg16Gly (rs1042713) polymorphism of ADRB2 gene.
Dmytriiev K; Mostovoy Y; Slepchenko N; Smereka Y
Monaldi Arch Chest Dis; 2022 Sep; 93(2):. PubMed ID: 36111412
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy.
Stolz D; Christ-Crain M; Bingisser R; Leuppi J; Miedinger D; Müller C; Huber P; Müller B; Tamm M
Chest; 2007 Jan; 131(1):9-19. PubMed ID: 17218551
[TBL] [Abstract][Full Text] [Related]
20. ADRB2 gene polymorphism and emphysema heterogeneity can modulate bronchodilator response in patients with emphysema.
Nojiri M; Mizuno S; Nishiki K; Kato R; Nakagawa K; Oikawa T; Iguchi M; Osanai K; Ishizaki T; Toga H
Pulm Pharmacol Ther; 2018 Feb; 48():80-87. PubMed ID: 28964817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
